MOTS-c, TRIM72 and Plasma-Membrane Repair

A multi-model study examined whether MOTS-c participates in membrane repair through interactions with TRIM72 and membrane lipids.

Study design

The researchers combined exercise-associated human observations with cell injury assays, protein-interaction studies, TRIM72-deficient mice and an ischaemia-reperfusion model.

What the researchers reported

The paper reported interactions between MOTS-c and TRIM72, enhanced trafficking of TRIM72 toward injured membrane, and membrane-related effects that were reduced when TRIM72 was absent. Additional interaction with a membrane phospholipid was reported.

What this result does not establish

The human component was correlational and the causal tests were preclinical. These findings do not establish a membrane-repair therapy or human clinical effect.

This article summarizes one published study about MOTS-c. It does not establish clinical efficacy, general safety, regulatory approval or suitability for human use. Findings should be interpreted within the model, methods and limitations of the original paper.